MedPath
HSA Approval

Fentanyl-hameln Injection 50 mcg/ml

SIN13542P

Fentanyl-hameln Injection 50 mcg/ml

Fentanyl-hameln Injection 50 mcg/ml

August 28, 2008

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

N01AH01

fentanyl

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Siegfried Hameln GmbH

Active Ingredients

Fentanyl Citrate 0.0785mg equivalent to Fentanyl

0.05mg/ml

Fentanyl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fentanyl-hameln Injection 50 mcg/ml - HSA Approval | MedPath